USANA Health Sciences, Inc. announced its financial results for the fiscal second quarter ended June 28, 2025. Consolidated net sales increased by 11% year-over-year to $236 million, driven primarily by the contribution from Hiya Health. Net earnings attributable to USANA decreased by 7% to $9.7 million, resulting in diluted EPS of $0.52.
Adjusted diluted EPS, however, saw a significant increase of 36% year-over-year to $0.74. Hiya, the direct-to-consumer business, contributed $34 million in net sales and reported 200,400 active monthly subscribers, with management confident in its growth outlook.
The company reiterated its full-year fiscal 2025 outlook for consolidated net sales between $920 million and $1.0 billion. USANA also announced it repaid the $23 million draw on its credit facility, ending the quarter debt-free with $151 million in cash and cash equivalents, and repurchased 528,000 shares for $15 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.